Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1277

1.

Effects of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFrEF.

Zile MR, O'Meara E, Claggett B, Prescott MF, Solomon SD, Swedberg K, Packer M, McMurray JJV, Shi V, Lefkowitz M, Rouleau J.

J Am Coll Cardiol. 2019 Feb 26;73(7):795-806. doi: 10.1016/j.jacc.2018.11.042.

PMID:
30784673
2.

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR.

Murray D, McMurray JL, Eldershaw S, Pearce H, Davies N, Scarisbrick JJ, Moss P.

Blood Adv. 2019 Feb 26;3(4):519-530. doi: 10.1182/bloodadvances.2018025114.

3.

Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial.

Ferreira JP, Abreu P, McMurray JJV, van Veldhuisen DJ, Swedberg K, Pocock SJ, Vincent J, Lins K, Rossignol P, Pitt B, Zannad F.

Eur J Heart Fail. 2019 Feb 15. doi: 10.1002/ejhf.1400. [Epub ahead of print]

PMID:
30768732
4.

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.

Vardeny O, Claggett B, Kachadourian J, Desai AS, Packer M, Rouleau J, Zile MR, Swedberg K, Lefkowitz M, Shi V, McMurray JJV, Solomon SD.

Eur J Heart Fail. 2019 Feb 11. doi: 10.1002/ejhf.1402. [Epub ahead of print]

PMID:
30741494
5.

Income Inequality and Outcomes in Heart Failure: A Global Between-Country Analysis.

Dewan P, Rørth R, Jhund PS, Ferreira JP, Zannad F, Shen L, Køber L, Abraham WT, Desai AS, Dickstein K, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV; PARADIGM-HF and ATMOSPHERE Investigators.

JACC Heart Fail. 2019 Feb 4. pii: S2213-1779(18)30839-4. doi: 10.1016/j.jchf.2018.11.005. [Epub ahead of print]

6.

Exploring the role of teams and technology in patients' medication decision making.

Mercer K, Guirguis L, Burns C, Chin J, Dogba MJ, Dolovich L, Guénette L, Jenkins L, Légaré F, McKinnon A, McMurray J, Waked K, Grindrod KA.

J Am Pharm Assoc (2003). 2019 Feb 5. pii: S1544-3191(18)30573-9. doi: 10.1016/j.japh.2018.12.010. [Epub ahead of print]

PMID:
30733151
7.

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction.

Rørth R, Dewan P, Kristensen SL, Jhund PS, Petrie MC, Køber L, McMurray JJV.

Clin Res Cardiol. 2019 Jan 28. doi: 10.1007/s00392-019-01415-z. [Epub ahead of print]

PMID:
30689020
8.

Metformin Use and Cardiovascular Events in Patients with Type 2 Diabetes and Chronic Kidney Disease.

Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA.

Diabetes Obes Metab. 2019 Jan 22. doi: 10.1111/dom.13642. [Epub ahead of print]

PMID:
30672083
9.

Real-world studies no substitute for RCTs in establishing efficacy.

Gerstein HC, McMurray J, Holman RR.

Lancet. 2019 Jan 19;393(10168):210-211. doi: 10.1016/S0140-6736(18)32840-X. No abstract available.

PMID:
30663582
10.

Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.

Seferovic JP, Bentley-Lewis R, Claggett B, Diaz R, Gerstein HC, Køber LV, Lawson FC, Lewis EF, Maggioni AP, McMurray JJV, Probstfield JL, Riddle MC, Solomon SD, Tardif JC, Pfeffer MA.

J Diabetes Res. 2018 Dec 16;2018:1631263. doi: 10.1155/2018/1631263. eCollection 2018.

11.

Response by Claggett et al to Letter Regarding Article, "Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical Trials".

Claggett B, Pocock S, Wei LJ, Pfeffer MA, McMurray JJV, Solomon SD.

Circulation. 2019 Jan 15;139(3):422-423. doi: 10.1161/CIRCULATIONAHA.118.038478. No abstract available.

PMID:
30640547
12.

Prevalence and profile of "seasonal frequent flyers" with chronic heart disease: Analysis of 1598 patients and 4588 patient-years follow-up.

Loader J, Chan YK, Hawley JA, Moholdt T, McDonald CF, Jhund P, Petrie MC, McMurray JJ, Scuffham PA, Ramchand J, Burrell LM, Stewart S.

Int J Cardiol. 2019 Mar 15;279:126-132. doi: 10.1016/j.ijcard.2018.12.060. Epub 2019 Jan 2.

PMID:
30638747
13.

Retrospective Evaluation of the Perioperative Management of Patients Undergoing Total Pancreatectomy With Islet Autotransplantation: Single Institution Review.

McSwain JR, Nykamp M, Wolf BJ, McMurray JD, Skorke CA, Clark CA.

Pancreas. 2019 Feb;48(2):228-232. doi: 10.1097/MPA.0000000000001236.

PMID:
30629028
14.

Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women.

Dewan P, Rørth R, Jhund PS, Shen L, Raparelli V, Petrie MC, Abraham WT, Desai AS, Dickstein K, Køber L, Mogensen UM, Packer M, Rouleau JL, Solomon SD, Swedberg K, Zile MR, McMurray JJV.

J Am Coll Cardiol. 2019 Jan 8;73(1):29-40. doi: 10.1016/j.jacc.2018.09.081.

15.

Buried Rib SiO2 Multimode Interference Waveguides for Optofluidic Multiplexing.

Stott MA, Ganjalizadeh V, Meena G, McMurray J, Olsen M, Orfila M, Schmidt H, Hawkins AR.

IEEE Photonics Technol Lett. 2018 Oct 15;30(16):1487-1490. doi: 10.1109/LPT.2018.2858258. Epub 2018 Jul 23.

PMID:
30618484
16.

Impact of eplerenone on major cardiovascular outcomes in patients with systolic heart failure according to baseline heart rate.

Chin KL, Collier T, Pocock S, Pitt B, McMurray JJV, van Veldhuisen DJ, Swedberg K, Vincent J, Zannad F, Liew D.

Clin Res Cardiol. 2019 Jan 2. doi: 10.1007/s00392-018-1410-4. [Epub ahead of print]

PMID:
30604047
17.

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA.

Am J Kidney Dis. 2018 Dec 19. pii: S0272-6386(18)31087-4. doi: 10.1053/j.ajkd.2018.10.006. [Epub ahead of print]

PMID:
30578152
18.

Heart Failure With Preserved Ejection Fraction in the Young.

Tromp J, MacDonald MR, Tay WT, Teng TK, Hung CL, Narasimhan C, Shimizu W, Ling LH, Ng TP, Yap J, McMurray JJV, Zile MR, Richards AM, Anand IS, Lam CSP.

Circulation. 2018 Dec 11;138(24):2763-2773. doi: 10.1161/CIRCULATIONAHA.118.034720.

PMID:
30565987
19.

The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes.

Rørth R, Jhund PS, Kristensen SL, Desai AS, Køber L, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.

Eur J Heart Fail. 2019 Jan;21(1):40-49. doi: 10.1002/ejhf.1359. Epub 2018 Dec 10.

PMID:
30537261
20.

Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the Americas.

Dewan P, Jhund PS, Shen L, Petrie MC, Abraham WT, Atif Ali M, Chen CH, Desai AS, Dickstein K, Huang J, Kiatchoosakun S, Kim KS, Køber L, Lai WT, Liao Y, Mogensen UM, Oh BH, Packer M, Rouleau JL, Shi V, Sibulo AS Jr, Solomon SD, Sritara P, Swedberg K, Tsutsui H, Zile MR, McMurray JJV.

Eur J Heart Fail. 2018 Dec 10. doi: 10.1002/ejhf.1347. [Epub ahead of print]

PMID:
30536678
21.

Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.

Srivastava PK, Claggett BL, Solomon SD, McMurray JJV, Packer M, Zile MR, Desai AS, Rouleau JL, Swedberg K, Fonarow GC.

JAMA Cardiol. 2018 Nov 28. doi: 10.1001/jamacardio.2018.3957. [Epub ahead of print]

PMID:
30484837
22.

A Wrist-Worn Strap with an Array of Electrodes for Robust Physiological Sensing.

Ibrahim B, McMurray J, Jafari AR.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:4313-4317. doi: 10.1109/EMBC.2018.8513238.

PMID:
30441308
23.

Who Benefits From a Defibrillator-Balancing the Risk of Sudden Versus Non-sudden Death.

Beggs SAS, Gardner RS, McMurray JJV.

Curr Heart Fail Rep. 2018 Dec;15(6):376-389. doi: 10.1007/s11897-018-0416-6. Review.

24.

Measurement reliability of phonation threshold pressure in pediatric subjects.

Hoffman MR, Scholp AJ, Hedberg CD, Lamb JR, Braden MN, McMurray JS, Jiang JJ.

Laryngoscope. 2018 Nov 8. doi: 10.1002/lary.27418. [Epub ahead of print]

PMID:
30408173
25.

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis.

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Tomson CRV, Wheeler DC, Winearls CG, Ford I; PIVOTAL Investigators and Committees.

N Engl J Med. 2019 Jan 31;380(5):447-458. doi: 10.1056/NEJMoa1810742. Epub 2018 Oct 26. Erratum in: N Engl J Med. 2019 Jan 14;:.

PMID:
30365356
26.

Comparison of saphenous and cephalic blood lactate concentrations in dogs with gastric dilatation and volvulus: 45 cases.

Oron LD, Klainbart S, Bruchim Y, McMurray J, Boysen S, Saar M, Kelmer E.

Can J Vet Res. 2018 Oct;82(4):271-277.

PMID:
30363379
27.

Anticoagulation, atherothrombosis, and heart failure: lessons from COMMANDER-HF and CORONA.

Beggs SAS, Jhund PS, McMurray JJV.

Eur Heart J. 2018 Oct 23. doi: 10.1093/eurheartj/ehy609. [Epub ahead of print] No abstract available.

PMID:
30357375
28.

IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.

Januzzi JL Jr, Packer M, Claggett B, Liu J, Shah AM, Zile MR, Pieske B, Voors A, Gandhi PU, Prescott MF, Shi V, Lefkowitz MP, McMurray JJV, Solomon SD.

Circ Heart Fail. 2018 Oct;11(10):e005133. doi: 10.1161/CIRCHEARTFAILURE.118.005133.

PMID:
30354399
29.

Diabetic cardiomyopathy.

Lee MMY, McMurray JJV, Lorenzo-Almorós A, Kristensen SL, Sattar N, Jhund PS, Petrie MC.

Heart. 2018 Oct 18. pii: heartjnl-2016-310342. doi: 10.1136/heartjnl-2016-310342. [Epub ahead of print] No abstract available.

PMID:
30337334
30.

Redefining heart failure phenotypes based on ejection fraction.

Campbell RT, Petrie MC, McMurray JJV.

Eur J Heart Fail. 2018 Dec;20(12):1634-1635. doi: 10.1002/ejhf.1325. Epub 2018 Oct 17. No abstract available.

PMID:
30328651
31.

Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.

Macdougall IC, White C, Anker SD, Bhandari S, Farrington K, Kalra PA, McMurray JJV, Murray H, Steenkamp R, Tomson CRV, Wheeler DC, Winearls CG, Ford I; on behalf of the PIVOTAL Trial investigators.

Am J Nephrol. 2018;48(4):260-268. doi: 10.1159/000493551. Epub 2018 Oct 10.

32.

Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al.

Ramires FJA, Martinez F, Gómez EA, Demacq C, Gimpelewicz CR, Rouleau JL, Solomon SD, Swedberg K, Zile MR, Packer M, McMurray JJV.

ESC Heart Fail. 2018 Dec;5(6):1069-1071. doi: 10.1002/ehf2.12355. Epub 2018 Oct 9. No abstract available.

33.

Talking to patients with heart failure about end of life.

Campbell RT, Petrie MC, McMurray JJV.

Eur J Heart Fail. 2018 Dec;20(12):1763-1765. doi: 10.1002/ejhf.1321. Epub 2018 Oct 8. No abstract available.

PMID:
30295978
34.

Comparing the Nonlinear Dynamic Acoustic Parameters of Healthy Adult and Pediatric Voices.

Chou A, Schrof C, Polce E, Braden M, McMurray J, Jiang J.

Ann Otol Rhinol Laryngol. 2018 Dec;127(12):937-945. doi: 10.1177/0003489418803394. Epub 2018 Oct 7.

PMID:
30295066
35.

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators.

Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

PMID:
30291013
36.

Physician and Pharmacist Medication Decision-Making in the Time of Electronic Health Records: Mixed-Methods Study.

Mercer K, Burns C, Guirguis L, Chin J, Dogba MJ, Dolovich L, Guénette L, Jenkins L, Légaré F, McKinnon A, McMurray J, Waked K, Grindrod KA.

JMIR Hum Factors. 2018 Sep 25;5(3):e24. doi: 10.2196/humanfactors.9891.

37.

Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials.

Rossello X, Ariti C, Pocock SJ, Ferreira JP, Girerd N, McMurray JJV, Van Veldhuisen DJ, Pitt B, Zannad F.

Clin Res Cardiol. 2018 Sep 27. doi: 10.1007/s00392-018-1378-0. [Epub ahead of print]

PMID:
30264282
38.

Impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction.

Rossello X, Ferreira JP, McMurray JJ, Aguilar D, Pfeffer MA, Pitt B, Dickstein K, Girerd N, Rossignol P, Zannad F; High-Risk Myocardial Infarction Database Initiative.

Eur Heart J Acute Cardiovasc Care. 2018 Sep 27:2048872618803701. doi: 10.1177/2048872618803701. [Epub ahead of print]

PMID:
30259764
39.

Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.

Voors AA, Shah SJ, Bax JJ, Butler J, Gheorghiade M, Hernandez AF, Kitzman DW, McMurray JJV, Wirtz AB, Lanius V, van der Laan M, Solomon SD.

Eur J Heart Fail. 2018 Nov;20(11):1601-1610. doi: 10.1002/ejhf.1295. Epub 2018 Sep 17.

PMID:
30225882
40.

Growth differentiation factor-15 is not modified by sacubitril/valsartan and is an independent marker of risk in patients with heart failure and reduced ejection fraction: the PARADIGM-HF trial.

Bouabdallaoui N, Claggett B, Zile MR, McMurray JJV, O'Meara E, Packer M, Prescott MF, Swedberg K, Solomon SD, Rouleau JL; PARADIGM-HF Investigators and Committees.

Eur J Heart Fail. 2018 Dec;20(12):1701-1709. doi: 10.1002/ejhf.1301. Epub 2018 Sep 11.

PMID:
30204280
41.

Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF).

Fudim M, Parikh KS, Dunning A, DeVore AD, Mentz RJ, Schulte PJ, Armstrong PW, Ezekowitz JA, Tang WHW, McMurray JJV, Voors AA, Drazner MH, O'Connor CM, Hernandez AF, Patel CB.

Am J Cardiol. 2018 Nov 1;122(9):1506-1512. doi: 10.1016/j.amjcard.2018.07.023. Epub 2018 Aug 3.

PMID:
30172362
42.

Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study.

Ueland T, Gullestad L, Kou L, Aukrust P, Anand IS, Broughton MN, McMurray JJ, van Veldhuisen DJ, Warren DJ, Bolstad N.

ESC Heart Fail. 2018 Dec;5(6):1052-1059. doi: 10.1002/ehf2.12312. Epub 2018 Aug 25.

43.

SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review.

Verma S, McMurray JJV.

Diabetologia. 2018 Oct;61(10):2108-2117. doi: 10.1007/s00125-018-4670-7. Epub 2018 Aug 22. Review.

PMID:
30132036
44.

Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study.

Rørth R, Fosbøl EL, Kragholm K, Mogensen UM, Jhund PS, Petrie MC, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL.

Clin Epidemiol. 2018 Aug 2;10:917-930. doi: 10.2147/CLEP.S164795. eCollection 2018.

45.

High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study.

Welsh P, Papacosta O, Ramsay S, Whincup P, McMurray J, Wannamethee G, Sattar N.

J Card Fail. 2018 Aug 11. pii: S1071-9164(18)30884-4. doi: 10.1016/j.cardfail.2018.08.002. [Epub ahead of print]

46.

Association is not causation: treatment effects cannot be estimated from observational data in heart failure.

Rush CJ, Campbell RT, Jhund PS, Petrie MC, McMurray JJV.

Eur Heart J. 2018 Oct 1;39(37):3417-3438. doi: 10.1093/eurheartj/ehy407.

47.

Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial.

Kraus WE, Yates T, Tuomilehto J, Sun JL, Thomas L, McMurray JJV, Bethel MA, Holman RR.

BMJ Open Diabetes Res Care. 2018 Jul 19;6(1):e000523. doi: 10.1136/bmjdrc-2018-000523. eCollection 2018.

48.

Catheter Ablation for Atrial Fibrillation with Heart Failure.

Docherty KF, Jhund PS, McMurray JJV.

N Engl J Med. 2018 Aug 2;379(5):491-2. doi: 10.1056/NEJMc1806519. No abstract available.

PMID:
30070094
49.

T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.

Abraityte A, Aukrust P, Kou L, Anand IS, Young J, Mcmurray JJV, van Veldhuisen DJ, Gullestad L, Ueland T.

Clin Res Cardiol. 2019 Feb;108(2):133-141. doi: 10.1007/s00392-018-1331-2. Epub 2018 Jul 26.

PMID:
30051179
50.

Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics.

Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV.

Am Heart J. 2018 Sep;203:30-38. doi: 10.1016/j.ahj.2018.03.030. Epub 2018 Jun 12.

PMID:
30015066

Supplemental Content

Loading ...
Support Center